Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ian Keyzor

A UK-Based Cost-Utility Analysis of Indacaterol, a Once-Daily Maintenance Bronchodilator for Patients With COPD, Using Real World Evidence on Resource Use

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2013English

Related publications

Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Thorax
PulmonaryRespiratory Medicine
2010English

Biologic Treatment Sequences for Plaque Psoriasis: A Cost-Utility Analysis Based on 10 Years of Dutch Real-World Evidence From BioCAPTURE

British Journal of Dermatology
DermatologyMedicine
2018English

Indacaterol Therapy in Patients With COPD Not Receiving Other Maintenance Treatment

Respiratory Medicine
PulmonaryRespiratory Medicine
2012English

Evaluating a Group-Based Maintenance Self-Management Intervention for Patients With COPD

2019English

Real-World Treatment of Patients With Multiple Sclerosis Per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany

Neurology and Therapy
Neurology
2019English

Real-World Studies in Infrequently Exacerbating Patients With COPD

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2019English

Clinical Benefit of Fixed-Dose Dual Bronchodilation With Glycopyrronium and Indacaterol Once Daily in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2014English

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Thorax
PulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy